Tianjin Development (HKG:0882) unit Lisheng Pharmaceutical subscribed for a total of 185 million yuan of investment products by Industrial Bank (SHA:601166), a Wednesday Hong Kong bourse filing said.
The eight agreements related to the investments, which were made to achieve a better return on idle funds, were entered into between March 31 and June 11.